Corcym has announced the first use of its Perceval Plus sutureless aortic heart valve in a robotic aortic valve replacement (RAVR) procedure, performed by cardiothoracic surgeon Marijan Koprivanac at Cleveland Clinic’s Heart, Vascular & Thoracic Institute in Cleveland, USA. The procedure represents an important milestone in surgical heart valve replacement, the company says in a press release.
The Corcym artificial heart valve was used alongside CardioPrecision’s CoreVista robot enabling platform, in what surgeons have dubbed an AVATAR—advanced videoscopic aortic valve surgery by transcervical approach using tobot assistance—procedure.
“This pioneering surgical procedure strengthens our foothold in robotic surgery,” said Christian Mazzi, chief executive officer of Corcym. “By having our sutureless valve technology be used in this way, we helped create a new option for robotic cardiac surgery.”
“Combining the artificial heart valve with this new surgical technology means patients should experience less pain and time in the hospital following heart surgery,” said Koprivanac. “In fact, we believe that this may be one of the least invasive surgical heart valve replacement options now available.”
“Robotic-assisted surgery is widely practiced across almost every other surgical specialty,” said Fraser Sutherland, CardioPrecision’s chief medical officer. “Now cardiac surgeons can offer patients this least invasive option using robotics with our innovative CoreVista platform, while ensuring their safety remains paramount.”
